Aesthetic Devices refers to devices used in cosmetic treatments such as Implants, Injectables, Laser Resurfacing and Body Contouring that are used to beautify, correct, and improve body contour. Aesthetic Injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance. GlobalData uses proprietary data and analytics to provide a comprehensive report on the aesthetic injectables market in Spain. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the aesthetic injectables market in Spain was Galderma followed by Allergan Aesthetics, Merz Pharma GmbH & Co, Sinclair Pharma and Teoxane.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Aesthetic Injectables helps in achieving a more youthful appearance by increasing the volume of sunken cheeks or temples, reducing lines around nose and mouth (marionette lines and smile lines), plumping up lips and enhancing facial contour. Aesthetic Injectables are classified based on their molecular composition. Aesthetic Injectables include Botulinum Toxin Type A, Hyaluronic Acid Fillers, and Non-Hyaluronic Acid Fillers.
The aesthetic injectables market in Spain can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size aesthetic injectables in Spain, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
